Gathering Groups is honoured to be partnering with Therapsil in what may be the world's largest and most innovative psilocybin clinical trial and research data repository, right here in Canada.

This large-scale trial, pending approval from Health Canada, will uniquely study the effects of psilocybin in a group program and, for the first time in history, will not necessitate any diagnosed mental health condition. This trial focuses on measuring improvements of general well-being.

We are hopeful that the trial results will usher in a new era of affordable and accessible psilocybin therapy conducted in a group structure for all those who seek healing, growth and preventative mental health care.

About the Clinical Research

Gathering Groups is currently working on approval for a pilot study examining the impact of Psilocybin for assisted group therapy. This Clinical trial has been designed to include those who are looking to improve their overall wellbeing, not just their diagnosed mental health conditions. We understand wellness to be multifactorial and multifaceted and this approach better reflects the potential of these medicines. Focusing on wellness will not only help to drastically increase access, but it will also massively expand the potential for novel research and development.

The trial is set to take place in Abbotsford, BC. The treatment will be done in groups of eight, with four healthcare professionals leading each journey.

Our hope is to discover how the Gathering Group protocol will improve patient outcomes and experience while providing a grounds for future development of Gathering protocols to develop outside of the study.

About the Study Population

Although trial participant seats are open to everyone, Gathering has chosen to open up its 240 total trial participation seats to organizations who are looking to transform and up-level the cohesiveness of their leadership team.

You are encouraged to participate in this legal group trial that aims to enhance team creativity, connection, and overall well-being.

Participants may or may not have any clinical diagnoses. This inclusive approach will help to normalize the program and reduce any stigma that may be attached to “needing” the program for a mental health condition.

Our study population has been left broad so that together TheraPsil and Gathering Groups can make Psilocybin accessible to those who are currently using it, and Canadians who wish to get well.

While the study is open to most Canadians, spots are limited and we will only accept qualifying organizations who are first to apply.

We are asking that Canadian organizations join us in our mission to make psilocybin more available to Canadians. Companies who feel called to be a part of this trial can donate to our clinical trial or fund a cohort for their leadership team. Funds go directly to creating a medical framework for psilocybin treatment here in Canada. 

Fill out the form below to submit your inquiry to participate in this upcoming trial.

TheraPsil GG Donation Form
Community is Healing
Subscription Form
© 2023 Gathering Groups
Apply Now
Back to Top